Progyny filing: Vanguard reports 0 shares (Amend. No.5)
Progyny Inc disclosure: The Vanguard Group filed Amendment No. 5 to a Schedule 13G/A reporting 0 shares beneficially owned, representing 0% of Progyny's common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Progyny Inc disclosure: The Vanguard Group filed Amendment No. 5 to a Schedule 13G/A reporting 0 shares beneficially owned, representing 0% of Progyny's common stock. The filing explains an internal realignment effective January 12, 2026, causing certain Vanguard subsidiaries to report holdings separately.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did The Vanguard Group report for PGNY in Amendment No. 5?
Why does the Schedule 13G/A show zero ownership for Vanguard?
Who signed the filing on behalf of The Vanguard Group for PGNY?
Does the amendment identify any other persons holding more than 5% of PGNY?
AI-generated analysis. How Rhea-AI works. Not financial advice.